Great Point Partners as of Dec. 31, 2024
Portfolio Holdings for Great Point Partners
Great Point Partners holds 26 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 8.3 | $18M | 505k | 34.96 | |
| Cytokinetics Com New (CYTK) | 8.0 | $17M | 360k | 47.04 | |
| Kalvista Pharmaceuticals (KALV) | 7.1 | $15M | 1.8M | 8.47 | |
| Miragen Therapeutics (VRDN) | 6.8 | $14M | 750k | 19.17 | |
| Pliant Therapeutics (PLRX) | 6.5 | $14M | 1.1M | 13.17 | |
| Abivax Sa Sponsored Ads (ABVX) | 5.7 | $12M | 1.6M | 7.32 | |
| Dynavax Technologies Corp Com New (DVAX) | 5.2 | $11M | 860k | 12.77 | |
| Neurogene (NGNE) | 4.8 | $10M | 443k | 22.86 | |
| Evolus (EOLS) | 4.7 | $9.9M | 896k | 11.04 | |
| Xenon Pharmaceuticals (XENE) | 4.5 | $9.6M | 245k | 39.20 | |
| Unicycive Therapeutics | 4.1 | $8.7M | 11M | 0.79 | |
| Zura Bio Class A Ord Shs (ZURA) | 3.7 | $7.9M | 3.2M | 2.50 | |
| Autolus Therapeutics Spon Ads (AUTL) | 3.3 | $7.1M | 3.0M | 2.35 | |
| Jasper Therapeutics Com New (JSPR) | 3.2 | $6.9M | 322k | 21.38 | |
| Merus N V (MRUS) | 3.1 | $6.6M | 158k | 42.05 | |
| Dianthus Therapeutics (DNTH) | 2.8 | $6.0M | 275k | 21.80 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 2.5 | $5.3M | 500k | 10.50 | |
| Upstream Bio (UPB) | 2.3 | $4.9M | 300k | 16.44 | |
| Context Therapeutics (CNTX) | 2.3 | $4.9M | 4.7M | 1.05 | |
| Voyager Therapeutics (VYGR) | 2.2 | $4.7M | 827k | 5.67 | |
| Oruka Therapeutics (ORKA) | 2.1 | $4.4M | 229k | 19.39 | |
| Mereo Biopharma Group Spon Ads (MREO) | 1.9 | $4.0M | 1.2M | 3.50 | |
| Rezolute Com New (RZLT) | 1.4 | $3.0M | 622k | 4.90 | |
| Promis Neurosciences Com New (PMN) | 1.2 | $2.5M | 2.6M | 0.95 | |
| Optinose Com New | 1.2 | $2.5M | 370k | 6.68 | |
| Urogen Pharma (URGN) | 0.9 | $2.0M | 188k | 10.65 |
